Advanced Renal Cell Carcinoma: Summarizing a Practical First-Line Treatment Algorithm

Dr. Monty Pal summarizes his practical first-line treatment algorithm for advanced renal cell carcinoma (RCC), highlighting how he incorporates disease risk, clinical presentation, and treatment goals into routine decision making. He reviews his preferred treatment approaches for patients with favorable-, intermediate-, and poor-risk disease, explaining the clinical circumstances that influence the selection of different immunotherapy-based regimens and the potential role of cytoreductive nephrectomy. Dr. Pal also discusses how considerations such as treatment tolerability and quality of life shape his therapeutic preferences alongside efficacy outcomes. In addition, he emphasizes the importance of clinical trial participation as a means of advancing the treatment landscape for advanced renal cell carcinoma. He concludes by discussing ongoing frontline clinical trials investigating microbiome-modulating strategies in combination with immunotherapy and encourages clinicians to consider appropriate trial enrollment to help generate future evidence and expand treatment options for patients with advanced renal cell carcinoma.